Industry Research Reports
Home > Reports > Chemical & Material > Global Vitamin C and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Vitamin C and Derivatives Market Outlook, In‑Depth Analysis & Forecast to 2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Vitamin C and Derivatives Market Size(US$)
CAGR 2025-2031
4.9%
Market Size,2031
USD 1,894
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,422 million
Market Forecast in 2031(Value)
US$ 1,894 million
CAGR
4.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Vitamin C and Derivatives market is projected to grow from US$ 1362 million in 2024 to US$ 1894 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
From a downstream perspective, Food & Beverage accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Vitamin C and Derivatives leading manufacturers including DSM, CSPC Pharma, Shandong Luwei, Northeast Pharma, North China Pharma, Shandong Tianli, Ningxia Qiyuan, Zhengzhou Tuoyang, Henan Huaxing, Jingjiang Hengtong, etc., dominate supply; the top five capture approximately % of global revenue, with DSM leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Vitamin C and Derivatives market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
- DSM
- CSPC Pharma
- Shandong Luwei
- Northeast Pharma
- North China Pharma
- Shandong Tianli
- Ningxia Qiyuan
- Zhengzhou Tuoyang
- Henan Huaxing
- Jingjiang Hengtong
- Henan Xinxiang Huaxing
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Food Grade
- Pharmaceutical Grade
- Feed Grade
Segment by Application
- Food & Beverage
- Pharmaceuticals & Healthcare
- Feed
- Cosmetics
- Others
Chapter Outline
Chapter 1: Defines the Vitamin C and Derivatives study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Introduction to Vitamin C and Derivatives: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Vitamin C and Derivatives Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.2.4 Feed Grade
1.3 Market Segmentation by Application
1.3.1 Global Vitamin C and Derivatives Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food & Beverage
1.3.3 Pharmaceuticals & Healthcare
1.3.4 Feed
1.3.5 Cosmetics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vitamin C and Derivatives Revenue Estimates and Forecasts 2020-2031
2.2 Global Vitamin C and Derivatives Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Vitamin C and Derivatives Sales Estimates and Forecasts 2020-2031
2.4 Global Vitamin C and Derivatives Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Vitamin C and Derivatives Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Vitamin C and Derivatives Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Vitamin C and Derivatives Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Food Grade Market Size by Manufacturers
4.5.2 Pharmaceutical Grade Market Size by Manufacturers
4.5.3 Feed Grade Market Size by Manufacturers
4.6 Global Vitamin C and Derivatives Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Vitamin C and Derivatives Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Vitamin C and Derivatives Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Vitamin C and Derivatives Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Vitamin C and Derivatives Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Vitamin C and Derivatives Sales and Revenue by Type (2020-2031)
7.4 North America Vitamin C and Derivatives Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Vitamin C and Derivatives Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Vitamin C and Derivatives Sales and Revenue by Type (2020-2031)
8.4 Europe Vitamin C and Derivatives Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Vitamin C and Derivatives Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Vitamin C and Derivatives Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Vitamin C and Derivatives Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Vitamin C and Derivatives Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Vitamin C and Derivatives Sales and Revenue by Type (2020-2031)
10.4 Central and South America Vitamin C and Derivatives Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Vitamin C and Derivatives Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Vitamin C and Derivatives Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Vitamin C and Derivatives Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Vitamin C and Derivatives Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 DSM
12.1.1 DSM Corporation Information
12.1.2 DSM Business Overview
12.1.3 DSM Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.1.4 DSM Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 DSM Vitamin C and Derivatives Sales by Product in 2024
12.1.6 DSM Vitamin C and Derivatives Sales by Application in 2024
12.1.7 DSM Vitamin C and Derivatives Sales by Geographic Area in 2024
12.1.8 DSM Vitamin C and Derivatives SWOT Analysis
12.1.9 DSM Recent Developments
12.2 CSPC Pharma
12.2.1 CSPC Pharma Corporation Information
12.2.2 CSPC Pharma Business Overview
12.2.3 CSPC Pharma Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.2.4 CSPC Pharma Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 CSPC Pharma Vitamin C and Derivatives Sales by Product in 2024
12.2.6 CSPC Pharma Vitamin C and Derivatives Sales by Application in 2024
12.2.7 CSPC Pharma Vitamin C and Derivatives Sales by Geographic Area in 2024
12.2.8 CSPC Pharma Vitamin C and Derivatives SWOT Analysis
12.2.9 CSPC Pharma Recent Developments
12.3 Shandong Luwei
12.3.1 Shandong Luwei Corporation Information
12.3.2 Shandong Luwei Business Overview
12.3.3 Shandong Luwei Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.3.4 Shandong Luwei Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Shandong Luwei Vitamin C and Derivatives Sales by Product in 2024
12.3.6 Shandong Luwei Vitamin C and Derivatives Sales by Application in 2024
12.3.7 Shandong Luwei Vitamin C and Derivatives Sales by Geographic Area in 2024
12.3.8 Shandong Luwei Vitamin C and Derivatives SWOT Analysis
12.3.9 Shandong Luwei Recent Developments
12.4 Northeast Pharma
12.4.1 Northeast Pharma Corporation Information
12.4.2 Northeast Pharma Business Overview
12.4.3 Northeast Pharma Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.4.4 Northeast Pharma Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Northeast Pharma Vitamin C and Derivatives Sales by Product in 2024
12.4.6 Northeast Pharma Vitamin C and Derivatives Sales by Application in 2024
12.4.7 Northeast Pharma Vitamin C and Derivatives Sales by Geographic Area in 2024
12.4.8 Northeast Pharma Vitamin C and Derivatives SWOT Analysis
12.4.9 Northeast Pharma Recent Developments
12.5 North China Pharma
12.5.1 North China Pharma Corporation Information
12.5.2 North China Pharma Business Overview
12.5.3 North China Pharma Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.5.4 North China Pharma Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 North China Pharma Vitamin C and Derivatives Sales by Product in 2024
12.5.6 North China Pharma Vitamin C and Derivatives Sales by Application in 2024
12.5.7 North China Pharma Vitamin C and Derivatives Sales by Geographic Area in 2024
12.5.8 North China Pharma Vitamin C and Derivatives SWOT Analysis
12.5.9 North China Pharma Recent Developments
12.6 Shandong Tianli
12.6.1 Shandong Tianli Corporation Information
12.6.2 Shandong Tianli Business Overview
12.6.3 Shandong Tianli Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.6.4 Shandong Tianli Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Shandong Tianli Recent Developments
12.7 Ningxia Qiyuan
12.7.1 Ningxia Qiyuan Corporation Information
12.7.2 Ningxia Qiyuan Business Overview
12.7.3 Ningxia Qiyuan Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.7.4 Ningxia Qiyuan Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Ningxia Qiyuan Recent Developments
12.8 Zhengzhou Tuoyang
12.8.1 Zhengzhou Tuoyang Corporation Information
12.8.2 Zhengzhou Tuoyang Business Overview
12.8.3 Zhengzhou Tuoyang Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.8.4 Zhengzhou Tuoyang Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Zhengzhou Tuoyang Recent Developments
12.9 Henan Huaxing
12.9.1 Henan Huaxing Corporation Information
12.9.2 Henan Huaxing Business Overview
12.9.3 Henan Huaxing Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.9.4 Henan Huaxing Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Henan Huaxing Recent Developments
12.10 Jingjiang Hengtong
12.10.1 Jingjiang Hengtong Corporation Information
12.10.2 Jingjiang Hengtong Business Overview
12.10.3 Jingjiang Hengtong Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.10.4 Jingjiang Hengtong Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Jingjiang Hengtong Recent Developments
12.11 Henan Xinxiang Huaxing
12.11.1 Henan Xinxiang Huaxing Corporation Information
12.11.2 Henan Xinxiang Huaxing Business Overview
12.11.3 Henan Xinxiang Huaxing Vitamin C and Derivatives Product Models, Descriptions and Specifications
12.11.4 Henan Xinxiang Huaxing Vitamin C and Derivatives Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Henan Xinxiang Huaxing Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Vitamin C and Derivatives Industry Chain
13.2 Vitamin C and Derivatives Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Vitamin C and Derivatives Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Vitamin C and Derivatives Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Vitamin C and Derivatives Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Vitamin C and Derivatives Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
Table of Figures
List of Tables
Table 1. Global Vitamin C and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Vitamin C and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Vitamin C and Derivatives Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Vitamin C and Derivatives Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Vitamin C and Derivatives Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global Vitamin C and Derivatives Sales by Region (2020-2025) & (K MT)
Table 8. Global Vitamin C and Derivatives Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Vitamin C and Derivatives Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global Vitamin C and Derivatives Production by Region (2020-2025) & (K MT)
Table 12. Global Vitamin C and Derivatives Production by Region (2026-2031) & (K MT)
Table 13. Global Vitamin C and Derivatives Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global Vitamin C and Derivatives Sales Share by Manufacturers (2020-2025)
Table 15. Global Vitamin C and Derivatives Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Vitamin C and Derivatives Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Vitamin C and Derivatives by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin C and Derivatives as of 2024)
Table 19. Global Vitamin C and Derivatives Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Vitamin C and Derivatives Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Vitamin C and Derivatives Manufacturing Base and Headquarters
Table 22. Global Vitamin C and Derivatives Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Vitamin C and Derivatives Sales by Type (2020-2025) & (K MT)
Table 26. Global Vitamin C and Derivatives Sales by Type (2026-2031) & (K MT)
Table 27. Global Vitamin C and Derivatives Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Vitamin C and Derivatives Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Vitamin C and Derivatives ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Vitamin C and Derivatives Sales by Application (2020-2025) & (K MT)
Table 32. Global Vitamin C and Derivatives Sales by Application (2026-2031) & (K MT)
Table 33. Vitamin C and Derivatives High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Vitamin C and Derivatives Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Vitamin C and Derivatives Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Vitamin C and Derivatives ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Vitamin C and Derivatives Growth Accelerators and Market Barriers
Table 40. North America Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Vitamin C and Derivatives Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Vitamin C and Derivatives Growth Accelerators and Market Barriers
Table 43. Europe Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Vitamin C and Derivatives Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Vitamin C and Derivatives Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Vitamin C and Derivatives Growth Accelerators and Market Barriers
Table 48. Southeast Asia Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Vitamin C and Derivatives Investment Opportunities and Key Challenges
Table 50. Central and South America Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Vitamin C and Derivatives Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Vitamin C and Derivatives Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. DSM Corporation Information
Table 54. DSM Description and Major Businesses
Table 55. DSM Product Models, Descriptions and Specifications
Table 56. DSM Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. DSM Sales Value Proportion by Product in 2024
Table 58. DSM Sales Value Proportion by Application in 2024
Table 59. DSM Sales Value Proportion by Geographic Area in 2024
Table 60. DSM Vitamin C and Derivatives SWOT Analysis
Table 61. DSM Recent Developments
Table 62. CSPC Pharma Corporation Information
Table 63. CSPC Pharma Description and Major Businesses
Table 64. CSPC Pharma Product Models, Descriptions and Specifications
Table 65. CSPC Pharma Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. CSPC Pharma Sales Value Proportion by Product in 2024
Table 67. CSPC Pharma Sales Value Proportion by Application in 2024
Table 68. CSPC Pharma Sales Value Proportion by Geographic Area in 2024
Table 69. CSPC Pharma Vitamin C and Derivatives SWOT Analysis
Table 70. CSPC Pharma Recent Developments
Table 71. Shandong Luwei Corporation Information
Table 72. Shandong Luwei Description and Major Businesses
Table 73. Shandong Luwei Product Models, Descriptions and Specifications
Table 74. Shandong Luwei Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Shandong Luwei Sales Value Proportion by Product in 2024
Table 76. Shandong Luwei Sales Value Proportion by Application in 2024
Table 77. Shandong Luwei Sales Value Proportion by Geographic Area in 2024
Table 78. Shandong Luwei Vitamin C and Derivatives SWOT Analysis
Table 79. Shandong Luwei Recent Developments
Table 80. Northeast Pharma Corporation Information
Table 81. Northeast Pharma Description and Major Businesses
Table 82. Northeast Pharma Product Models, Descriptions and Specifications
Table 83. Northeast Pharma Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Northeast Pharma Sales Value Proportion by Product in 2024
Table 85. Northeast Pharma Sales Value Proportion by Application in 2024
Table 86. Northeast Pharma Sales Value Proportion by Geographic Area in 2024
Table 87. Northeast Pharma Vitamin C and Derivatives SWOT Analysis
Table 88. Northeast Pharma Recent Developments
Table 89. North China Pharma Corporation Information
Table 90. North China Pharma Description and Major Businesses
Table 91. North China Pharma Product Models, Descriptions and Specifications
Table 92. North China Pharma Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. North China Pharma Sales Value Proportion by Product in 2024
Table 94. North China Pharma Sales Value Proportion by Application in 2024
Table 95. North China Pharma Sales Value Proportion by Geographic Area in 2024
Table 96. North China Pharma Vitamin C and Derivatives SWOT Analysis
Table 97. North China Pharma Recent Developments
Table 98. Shandong Tianli Corporation Information
Table 99. Shandong Tianli Description and Major Businesses
Table 100. Shandong Tianli Product Models, Descriptions and Specifications
Table 101. Shandong Tianli Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Shandong Tianli Recent Developments
Table 103. Ningxia Qiyuan Corporation Information
Table 104. Ningxia Qiyuan Description and Major Businesses
Table 105. Ningxia Qiyuan Product Models, Descriptions and Specifications
Table 106. Ningxia Qiyuan Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Ningxia Qiyuan Recent Developments
Table 108. Zhengzhou Tuoyang Corporation Information
Table 109. Zhengzhou Tuoyang Description and Major Businesses
Table 110. Zhengzhou Tuoyang Product Models, Descriptions and Specifications
Table 111. Zhengzhou Tuoyang Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Zhengzhou Tuoyang Recent Developments
Table 113. Henan Huaxing Corporation Information
Table 114. Henan Huaxing Description and Major Businesses
Table 115. Henan Huaxing Product Models, Descriptions and Specifications
Table 116. Henan Huaxing Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Henan Huaxing Recent Developments
Table 118. Jingjiang Hengtong Corporation Information
Table 119. Jingjiang Hengtong Description and Major Businesses
Table 120. Jingjiang Hengtong Product Models, Descriptions and Specifications
Table 121. Jingjiang Hengtong Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Jingjiang Hengtong Recent Developments
Table 123. Henan Xinxiang Huaxing Corporation Information
Table 124. Henan Xinxiang Huaxing Description and Major Businesses
Table 125. Henan Xinxiang Huaxing Product Models, Descriptions and Specifications
Table 126. Henan Xinxiang Huaxing Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Henan Xinxiang Huaxing Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitamin C and Derivatives Product Picture
Figure 2. Global Vitamin C and Derivatives Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Food Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Feed Grade Product Picture
Figure 6. Global Vitamin C and Derivatives Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Food & Beverage
Figure 8. Pharmaceuticals & Healthcare
Figure 9. Feed
Figure 10. Cosmetics
Figure 11. Others
Figure 12. Vitamin C and Derivatives Report Years Considered
Figure 13. Global Vitamin C and Derivatives Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 15. Global Vitamin C and Derivatives Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Vitamin C and Derivatives Revenue Market Share by Region (2020-2031)
Figure 17. Global Vitamin C and Derivatives Sales (2020-2031) & (K MT)
Figure 18. Global Vitamin C and Derivatives Sales (CAGR) by Region (2020-2031) (K MT)
Figure 19. Global Vitamin C and Derivatives Sales Market Share by Region (2020-2031)
Figure 20. Global Vitamin C and Derivatives Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 21. Global Vitamin C and Derivatives Production Trend by Region (2020-2031) (K MT)
Figure 22. Global Vitamin C and Derivatives Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. Vitamin C and Derivatives Production Growth Rate in North America (2020-2031) & (K MT)
Figure 25. Vitamin C and Derivatives Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 26. Vitamin C and Derivatives Production Growth Rate in China (2020-2031) & (K MT)
Figure 27. Vitamin C and Derivatives Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 28. Top 5 and Top 10 Manufacturers Vitamin C and Derivatives Sales Volume Market Share in 2024
Figure 29. Global Vitamin C and Derivatives Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. Food Grade Revenue Market Share by Manufacturer in 2024
Figure 32. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024
Figure 33. Feed Grade Revenue Market Share by Manufacturer in 2024
Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 36. Global Vitamin C and Derivatives Sales Market Share by Type (2020-2031)
Figure 37. Global Vitamin C and Derivatives Revenue Market Share by Type (2020-2031)
Figure 38. Global Vitamin C and Derivatives Sales Market Share by Application (2020-2031)
Figure 39. Global Vitamin C and Derivatives Revenue Market Share by Application (2020-2031)
Figure 40. North America Vitamin C and Derivatives Sales YoY (2020-2031) & (K MT)
Figure 41. North America Vitamin C and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers Vitamin C and Derivatives Sales Revenue (US$ Million) in 2024
Figure 43. North America Vitamin C and Derivatives Sales Volume (K MT) by Type (2020- 2031)
Figure 44. North America Vitamin C and Derivatives Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America Vitamin C and Derivatives Sales Volume (K MT) by Application (2020-2031)
Figure 46. North America Vitamin C and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 48. Canada Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 50. Europe Vitamin C and Derivatives Sales YoY (2020-2031) & (K MT)
Figure 51. Europe Vitamin C and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers Vitamin C and Derivatives Sales Revenue (US$ Million) in 2024
Figure 53. Europe Vitamin C and Derivatives Sales Volume (K MT) by Type (2020-2031)
Figure 54. Europe Vitamin C and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe Vitamin C and Derivatives Sales Volume (K MT) by Application (2020-2031)
Figure 56. Europe Vitamin C and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 58. France Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 60. Italy Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 61. Russia Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Vitamin C and Derivatives Sales YoY (2020-2031) & (K MT)
Figure 63. Asia-Pacific Vitamin C and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers Vitamin C and Derivatives Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific Vitamin C and Derivatives Sales Volume (K MT) by Type (2020- 2031)
Figure 66. Asia-Pacific Vitamin C and Derivatives Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific Vitamin C and Derivatives Sales Volume (K MT) by Application (2020-2031)
Figure 68. Asia-Pacific Vitamin C and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 70. Japan Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 73. India Vitamin C and Derivatives Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America Vitamin C and Derivatives Sales YoY (2020-2031) & (K MT)
Figure 75. Central and South America Vitamin C and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers Vitamin C and Derivatives Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America Vitamin C and Derivatives Sales Volume (K MT) by Type (2021-2031)
Figure 78. Central and South America Vitamin C and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America Vitamin C and Derivatives Sales Volume (K MT) by Application (2020-2031)
Figure 80. Central and South America Vitamin C and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa Vitamin C and Derivatives Sales YoY (2020-2031) & (K MT)
Figure 84. Middle East and Africa Vitamin C and Derivatives Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers Vitamin C and Derivatives Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa Vitamin C and Derivatives Sales Volume (K MT) by Type (2021-2031)
Figure 87. South America Vitamin C and Derivatives Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa Vitamin C and Derivatives Sales Volume (K MT) by Application (2020-2031)
Figure 89. Middle East and Africa Vitamin C and Derivatives Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa Vitamin C and Derivatives Revenue (2020-2025) & (US$ Million)
Figure 94. Vitamin C and Derivatives Industry Chain Mapping
Figure 95. Regional Vitamin C and Derivatives Manufacturing Base Distribution (%)
Figure 96. Vitamin C and Derivatives Production Process
Figure 97. Regional Vitamin C and Derivatives Production Cost Structure
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
Related Reports
Global Vitamin C and Derivatives Market Research Report 2024
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published Date: 2024-01-31
Pages: 104
USD 2900.00
(Single User License)
Global Vitamin C and Derivatives Market Insights, Forecast to 2030
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published Date: 2024-04-06
Pages: 113
USD 4900.00
(Single User License)
Global Vitamin C and Derivatives Market Research Report 2025
The global market for Vitamin C and Derivatives was valued at US$ 1362 million in the year 2024 and is projected to reach a revised size of US$ 1894 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-02-20
Pages: 102
USD 2900.00
(Single User License)
Vitamin C and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 112
USD 3950.00
(Single User License)
Global Vitamin C and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin C and Derivatives market size was US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 96
USD 4250.00
(Single User License)
Global Vitamin C and Derivatives Market Research Report 2026
The global Vitamin C and Derivatives market was valued at US$ 1422 million in 2025 and is anticipated to reach US$ 1978 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 137
USD 2900.00
(Single User License)
Vitamin C and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1422 million in 2025 and is projected to reach US$ 1978 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 137
USD 3950.00
(Single User License)
Global Vitamin C and Derivatives Market Research Report 2024
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published: 2024-01-31
Pages: 104
USD 2900.00 (Single User License)Global Vitamin C and Derivatives Market Insights, Forecast to 2030
Vitamin c not only prevents scurvy but also has a positive effect on skin quality: it helps increase collagen synthesis, provides mild exfoliating benefits and inhibits melanin production. Apart from pure vitamin c, all other derivatives have to be converted into ascorbic acid by the cells in order for the skin to utilize them for collagen production.
Published: 2024-04-06
Pages: 113
USD 4900.00 (Single User License)Global Vitamin C and Derivatives Market Research Report 2025
The global market for Vitamin C and Derivatives was valued at US$ 1362 million in the year 2024 and is projected to reach a revised size of US$ 1894 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-02-20
Pages: 102
USD 2900.00 (Single User License)Vitamin C and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 112
USD 3950.00 (Single User License)Global Vitamin C and Derivatives Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Vitamin C and Derivatives market size was US$ 1362 million in 2024 and is forecast to a readjusted size of US$ 1894 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 96
USD 4250.00 (Single User License)Global Vitamin C and Derivatives Market Research Report 2026
The global Vitamin C and Derivatives market was valued at US$ 1422 million in 2025 and is anticipated to reach US$ 1978 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-21
Pages: 137
USD 2900.00 (Single User License)Vitamin C and Derivatives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vitamin C and Derivatives was estimated to be worth US$ 1422 million in 2025 and is projected to reach US$ 1978 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-07-09
Pages: 137
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research